Daily FNArena News - Australia

The RBA today bowed to the pressure of recent data and lifted its cash rate to 4.00%.

Southern Cross Equities believes tissue repair technology play bioMD offers upside as its clinical trials are progressing.

Economists at TD Securities are worried the RBA might be too relaxed about inflation.

BA-ML has removed Toll from its in-house favourites, while chartists believe we may have seen the high for crude oil already.

Australian capital expenditure numbers for the December quarter were stronger than anticipated, adding weight to expectations for a rate hike next month.

December quarter wages in Australia rose less than the market had expected.

S&P will announce index changes next week, plus earnings estimates are not genuinely moving higher and what’s happening with Telstra?

Stockbrokers remain positive on the outlook for broadband provider iiNet.

Commonwealth Bank’s Business Sales Indicator has closely tracked Australian retail sales in recent months and its latest reading suggests a flat outcome in January.

Following reports from CBA, Bendigo and Westpac, Australia’s banking sector looks in sound health. But do brokers see near term value at these levels?